Marker Therapeutics (MRKR) Revenue (2016 - 2025)
Marker Therapeutics (MRKR) posted quarterly Revenue of $1.1 million for Q4 2025, down 51.0% year-over-year from $2.3 million in Q4 2024, and down 10.5% quarter-over-quarter from $1.2 million in Q3 2025.
Marker Therapeutics (MRKR) Revenue (2016 - 2025) Analysis & Trends
Marker Therapeutics (MRKR) has reported Revenue for 9 consecutive years, with $1.1 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Revenue fell 51.0% year-over-year to $1.1 million; the TTM figure through Dec 2025 stood at $3.5 million (down 52.21% YoY), while the FY2025 annual figure was $3.5 million, down 46.19% from the prior year.
- Revenue retreated to $1.1 million in Q4 2025 per MRKR's latest filing, from $1.2 million in the prior quarter.
- Across five years, Revenue topped out at $2.5 million in Q1 2023 and bottomed at -$503005.0 in Q2 2023.
- Historically, Revenue has averaged $1.1 million across 4 years, with a median of $999571.0 in 2022.
- Annual changes were most pronounced in 2023 — Revenue tumbled 163.63% — and 2024, when it soared 647.66%.
- Marker Therapeutics' Revenue stood at $759143.0 in 2022, then slumped by 66.07% to $257606.0 in 2023, then soared by 774.11% to $2.3 million in 2024, then slumped by 51.0% to $1.1 million in 2025.
- Business Quant data shows MRKR's Revenue at $1.1 million in Q4 2025, $1.2 million in Q3 2025, and $861184.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 145.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 1.71 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.29 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 425.49 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 674.14 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 1.06 Bn |
| 10 | Marker Therapeutics | 23.95 Mn | 12.02 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.10 Mn |
| Sep 30, 2025 | 1.23 Mn |
| Jun 30, 2025 | 861,184.00 |
| Mar 31, 2025 | 349,104.00 |
| Dec 31, 2024 | 2.25 Mn |
| Sep 30, 2024 | 1.93 Mn |
| Jun 30, 2024 | 2.00 Mn |
| Mar 31, 2024 | 1.24 Mn |
| Sep 30, 2023 | 257,606.00 |
| Jun 30, 2023 | -503,005.00 |
| Mar 31, 2023 | 2.50 Mn |
| Dec 31, 2022 | 759,143.00 |
| Sep 30, 2022 | 999,571.00 |
| Jun 30, 2022 | 790,508.00 |
| Mar 31, 2022 | 964,322.00 |
| Dec 31, 2020 | 33,215.00 |
| Jun 30, 2020 | 466,785.00 |
| Dec 31, 2019 | 200,000.00 |
| Jun 30, 2018 | 205,994.00 |
| Sep 30, 2017 | 183,064.00 |